Stuart Johnston Knechtle
William R. Kenan, Jr. Distinguished Professor of Surgery · Duke Department of Medicine
Credentials: · · ·
History
- Present
Duke Department of Medicine
- Present
Duke Department of Medicine
- Present
Duke Department of Medicine
Research
Risk factors for primary dysfunction after liver transplantation--a multivariate analysis
Transplantation · 1993 · 889 citations
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
Proceedings of the National Academy of Sciences of the United States of America · 1997 · Last of 10 authors · 746 citations
Nature Medicine · 1999 · 645 citations
125 papers · 22 as a fellow
- RS
119 papers
- JP
110 papers
- MK
87 papers
43 papers · 26 as a fellow
- YB
30 papers · 3 as a resident
29 papers · 5 as a fellow
28 papers
Grants
- 2026–2031
Donor-Specific Transplant Tolerance by Immune Reset
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.2M · Duke University
- 2021–2028
Targeting the B Cell Response to Treat Antibody-Mediated Rejection
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $11.8M · Duke University
- 2017–2028
The Risks and Opportunities of Homeostatic Repopulation
National Institute of Allergy and Infectious Diseases · U19
Contact PI · $27.2M · Duke University
- 2020–2022
Measuring the Impact of Allosensitization on Xenotransplantation
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $442.8K · Duke University
Clinical trials
- 2026–2027
Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Principal investigator · Recruiting · Phase 1
National Institute of Allergy and Infectious Diseases (NIAID)
- 2020
Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
Principal investigator · Terminated · Phase 1
Stuart Knechtle, M.D.
- 2016–2021
- 2008–2010
Phase 2 Study of the Safety of Diannexin in Kidney Transplant Recipients
Principal investigator · Completed · Phase 2
Alavita Pharmaceuticals Inc